Skip to main content
. 2019 Aug 20;2(4):e201800213. doi: 10.26508/lsa.201800213

Figure S7. Suboptimal efficacy of IRC117539 in vivo in CRPC models.

Figure S7.

(A, B) Tumor weight (A) and PSA levels in peripheral blood (B) of castration-resistant LNCaP xenograft mouse models treated as indicated. MDV3100: enzalutamide. Data are presented as mean ± SEM (n > 3).